Armistice Capital’s Zymeworks ZYME Stock Holding History

Armistice Capital’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,785,000	Closed	-$35.6M	–	241
2022 Q3	$35.6M	Buy	5,785,000 +13,000	+0.2%	+$78.4K	0.62%	42
2022 Q2	$30.6K	Buy	5,772,000 +12,000	+0.2%	+$72.6K	0.53%	47
2022 Q1	$37.7M	Buy	5,760,000 +4,509,803	+361%	+$40.2M	0.73%	41
2021 Q4	$20.5M	Sell	1,250,197 -1,273,803	-50%	-$26.6M	0.34%	67
2021 Q3	$73.3M	Buy	2,524,000 +524,000	+26%	+$17.4M	1.24%	15
2021 Q2	$69.4M	Buy	2,000,000 +350,000	+21%	+$11.1M	1.24%	18
2021 Q1	$52.1M	Buy	1,650,000 +1,200,000	+267%	+$48.8M	1.2%	23
2020 Q4	$21.3M	Sell	450,000 -266,000	-37%	-$12.4M	0.72%	43
2020 Q3	$33.4M	Sell	716,000 -62,000	-8%	-$2.13M	1.21%	27
2020 Q2	$28.1M	Buy	+778,000	New	+$28.7M	1.23%	31

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Armistice Capital's ZYME Position: Q4 2022 in Review

Armistice Capital sold out of Zymeworks (ZYME) in Q4 2022, closing a stake of 5,785,000 shares — an estimated $35.6M sold.

Armistice Capital first reported a position in ZYME in Q2 2020 and held it in 10 quarters. The position peaked at $73.3M in Q3 2021. 96 funds tracked by Wall St. Rank hold ZYME as of Q4 2022.

Armistice Capital reported no remaining Zymeworks position as of Q4 2022 after selling out during the quarter.
Armistice Capital sold 5,785,000 Zymeworks shares in Q4 2022, an estimated $35.6M.
Armistice Capital first reported a position in Zymeworks in Q2 2020 and held it in 10 quarters.
Armistice Capital's Zymeworks position peaked at $73.3M in Q3 2021.
96 funds tracked by Wall St. Rank held Zymeworks as of Q4 2022.

Based on Armistice Capital's 13F filing for Q4 2022, filed 14 Feb 2023.